Investor Relations

Press Releases

 
Press Releases
  Date Title View
May 31, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 31, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company's business at the Jefferies 2017 Global Healthcare Conference in New Yo...
Apr 27, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 27, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to $250 million of the company's common stock. This program will became effective immediately, and will remain open through December 31, 2017. ...
Apr 26, 2017
ROCK HILL, S.C. and SILVER SPRING, Md., April 26, 2017 /PRNewswire/ -- 3D Systems (NYSE: DDD) and United Therapeutics Corporation (NASDAQ: UTHR) today announced plans to develop solid-organ scaffolds for human transplants.  The multi-year collaboration and development agreement combines the 3D printing and precision healthcare expertise of 3D Syste...
Apr 26, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 26, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2017. "Our quarterly financial growth trends are slower than we would like as we are seeing more patients stay longer on front-line pulm...
Apr 19, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its first quarter 2017 financial results before the market opens on Wednesday, April 26, 2017. United Therapeutics will host a teleconference on Wednesday, April 26, 2017, at 9...
Apr 3, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 3, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that regulatory delays will result in postponement of the planned U.S. launch of the RemoSynch™ Implantable System for Remodulin® until 2018. "United Therapeutics' commitment to bringing...
Mar 31, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 31, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Patent and Trademark's Office (USPTO) Patent Trial and Appeal Board (PTAB) issued a Final Written Decision in connection with the inter partes review (IPR) of United Therapeutics' U.S. Pate...
Mar 9, 2017
MANHASSET, N.Y. and SILVER SPRING, Md., March 9, 2017 /PRNewswire/ -- Northwell Health's Feinstein Institute for Medical Research and United Therapeutics Corporation (NASDAQ: UTHR) announced today a strategic partnership focused on the application of bioelectronic medicine and cell therapy to cardiology, hypertension and post-transplant tolerance i...
Mar 7, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Barclays Global Healthcare Conference in Mi...
Feb 28, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Cowen and Company 37th Annual Health Care C...
1
... NextLast
= add release to Briefcase